BONESUPPORT™ APPOINTS ANNA STEGMARK EVP QM & RA

Published: 2024-06-12

BONESUPPORT AB a leading company in orthobiologics for the management of bone injuries, today announces that Anna Stegmark has been appointed EVP Quality Management & Regulatory Affairs with effect from 1 July 2024. She will also be part of the management team.

Anna Stegmark’s professional career comprises more than 19 years in the medical device sector, leading global quality and regulatory teams since 2010. Most recently, she was with Radiometer Medical as Director QA Operation.

For more information contact:

BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 591 million in 2023. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

BONESUPPORT™ APPOINTS ANNA STEGMARK EVP QM & RA